No Detail Found!

HBV and HCV Seroprevalence in Hospital Admissions for Thalassemia Major in Bengbu, China

Author(s)
Jun Zhang Department of Blood Transfusion, The First Afiliated Hospital of Bengbu Medical College,Bengbu, 233004, China
Xiaocao Xu School of Laboratory Medical, Bengbu Medical College, Bengbu, 233030, China
Min Cao School of Laboratory Medical, Bengbu Medical College, Bengbu, 233030, China
Abstract
Patients with thalassemia major are exposed to a wide range of blood transition viruses that among them hepatitis B and C viruses are in high significance. This study investigates the seroprevalence of HBV and HCV in hospital admissions for thalassemia major in Bengbu, China. This study is a cross-sectional study in which information was extracted and collected from patients' records, including gender, age, number of blood transfusions per year, HBs-Ag, HCV-Ab and Anti-HBs. The study included 630 thalassemia major patients who received regular blood transfusions at a hospital in Bengbu, China. We found that out of 630 patients of the study, there were three HBs-Ag positive, so the prevalence of HBV in this study is 0.5%. The prevalence of HCV-Ab positive was 7.1 and these individuals had a significantly older mean age than those with HCV-Ab negative. In 89.8% of patients the HBs-Ab titer was more than 10. Due to the progress of screening and selection of blood donors the prevalence of HBV infection in high-risk patients has sharply decreased in recent years. Vaccination is one of the most important protective factors in this group of the population. Therefore, administration of a reminder dose based on antibody titer is recommended in these individuals.
Publication Details
Page(s) 1951-1954
Published Journal: Pakistan Journal of Zoology, Volume: 54, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
HBV, Seroprevalence, Thalassemia, HBs-Ag, Blood transition
0

Citations

0

Downloads

159

Views